How do you pay?

How to pay the least

Ask for the cash price

Trutakna

Trutakna is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold.

  1. Ask your pharmacy for Trutakna’s cash price, and one or two other pharmacies too.
  2. Trutakna’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameTrutakna
Authorized genericatacicept
Regular genericatacicept
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldAsk the pharmacy
Same as Trutakna?
The original
–
–

Brand nameThe maker’s card

Tru Support Copay Program

Savings card from Vera Therapeutics

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $0 a fill

Sign up on trutakna.com 

Or call 1-800-729-8591.

In the maker’s words

“Tru Support may be able to help you lower your TRUTAKNA copay to as little as $0 if you’re commercially insured and eligible…”

From the maker’s offer on trutakna.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Trutakna itself, from the same company, sold without the brand name, and usually for less. For now Trutakna is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

Trutakna is a biologic. Biologics don’t have generics, but some have biosimilars or an unbranded version from the same maker. Ask your pharmacist or prescriber whether one is sold. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

TRUTAKNA is a B-lymphocyte stimulator (BLyS)-specific inhibitor and A Proliferation Inducing Ligand (APRIL) blocker indicated to reduce proteinuria in adults with primary immunoglobulin A nephropathy (IgAN) at risk for disease progression..

This indication is approved under accelerated approval based on a reduction of proteinuria. It has not been established whether TRUTAKNA slows kidney function decline over the long-term in patients with IgAN. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory clinical trial.

Source: the FDA label for Trutakna (Vera Therapeutics, Inc), August 5, 2026. Full label on DailyMed 

Good to know